220 related articles for article (PubMed ID: 31391786)
21. Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation.
Han R; Song Z; Li H; Wang C; Zhang L; Yang X
Sci Rep; 2023 Sep; 13(1):14497. PubMed ID: 37666835
[TBL] [Abstract][Full Text] [Related]
22. No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.
Demeestere I; Brice P; Peccatori FA; Kentos A; Dupuis J; Zachee P; Casasnovas O; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
J Clin Oncol; 2016 Aug; 34(22):2568-74. PubMed ID: 27217453
[TBL] [Abstract][Full Text] [Related]
23. Medical approaches to preservation of fertility in female cancer patients.
Del Mastro L; Giraudi S; Levaggi A; Pronzato P
Expert Opin Pharmacother; 2011 Feb; 12(3):387-96. PubMed ID: 21254946
[TBL] [Abstract][Full Text] [Related]
24. Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?
Bedoschi G; Turan V; Oktay K
Curr Breast Cancer Rep; 2013 Dec; 5(4):302-308. PubMed ID: 24707345
[TBL] [Abstract][Full Text] [Related]
25. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
[TBL] [Abstract][Full Text] [Related]
26. GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer.
Zhong Y; Lin Y; Cheng X; Huang X; Zhou Y; Mao F; Wang Y; Guan J; Shen S; Xu Y; Peng L; Li Y; Cao X; Sun Q
J Cancer; 2019; 10(18):4278-4285. PubMed ID: 31413747
[No Abstract] [Full Text] [Related]
27. Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.
Lambertini M; Del Mastro L; Viglietti G; Pondé NF; Solinas C; de Azambuja E
Curr Treat Options Oncol; 2017 Jan; 18(1):4. PubMed ID: 28185173
[TBL] [Abstract][Full Text] [Related]
28. Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer.
Abdel-Razeq H
Cancer Manag Res; 2019; 11():4273-4282. PubMed ID: 31190993
[TBL] [Abstract][Full Text] [Related]
29. Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer.
Sinha N; Letourneau JM; Wald K; Xiong P; Imbar T; Li B; Harris E; Mok-Lin E; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Oct; 35(10):1861-1868. PubMed ID: 30066303
[TBL] [Abstract][Full Text] [Related]
30. Gonadotropin-Releasing Hormone Agonists during Gonadal Chemotherapy for the Effect on Pregnancy Outcome and Ovarian Function in Premenopausal Patients with Breast Cancer: A Systematic Review and Meta-Analysis.
Yuan Y; Zhang C; Lei X; Ren T; Chen H; Zhao Q
Breast Care (Basel); 2023 Aug; 18(4):270-278. PubMed ID: 37900550
[TBL] [Abstract][Full Text] [Related]
31. Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis.
Shen YW; Zhang XM; Lv M; Chen L; Qin TJ; Wang F; Yang J; Liu PJ; Yang J
Onco Targets Ther; 2015; 8():3349-59. PubMed ID: 26622183
[TBL] [Abstract][Full Text] [Related]
32. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
[TBL] [Abstract][Full Text] [Related]
33. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
34. Endocrine prevention of chemotherapy-induced ovarian failure.
Blumenfeld Z; Evron A
Curr Opin Obstet Gynecol; 2016 Aug; 28(4):223-9. PubMed ID: 27253235
[TBL] [Abstract][Full Text] [Related]
35. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
Turner NH; Partridge A; Sanna G; Di Leo A; Biganzoli L
Ann Oncol; 2013 Sep; 24(9):2224-35. PubMed ID: 23709175
[TBL] [Abstract][Full Text] [Related]
36. Conservative management of reproductive cancers. Ovarian protection during treatment.
Cui W; Phillips KA
Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():49-58. PubMed ID: 30150091
[TBL] [Abstract][Full Text] [Related]
37. Preservation of ovarian function and fertility despite gonadotoxic chemotherapy.
Blumenfeld Z
Expert Rev Endocrinol Metab; 2012 Sep; 7(5):567-576. PubMed ID: 30780892
[TBL] [Abstract][Full Text] [Related]
38. Strategies for fertility preservation in young early breast cancer patients.
Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
[TBL] [Abstract][Full Text] [Related]
39. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.
Lambertini M; Ceppi M; Poggio F; Peccatori FA; Azim HA; Ugolini D; Pronzato P; Loibl S; Moore HC; Partridge AH; Bruzzi P; Del Mastro L
Ann Oncol; 2015 Dec; 26(12):2408-19. PubMed ID: 26347105
[TBL] [Abstract][Full Text] [Related]
40. Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation.
Cima LN; Colita A; Fica S
Endocr Connect; 2017 Nov; 6(8):R162-R170. PubMed ID: 28947558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
